HIV, hepatitis B, and hepatitis C screening in primary care
Part of Digestive system, Infections clinical trials.
This study tests a new way to help primary care doctors remember to screen their adult patients for HIV, hepatitis B, and hepatitis C. It aims to make sure more people get tested for these infections during regular checkups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a primary care doctor or nurse practitioner.
- You have been working in your current practice for at least 12 months.
- You plan to stay in your current practice for at least the next 12 months.
- You are not a specialist (like a cardiologist or dermatologist) or a pediatrician.
- You are willing to participate and give your consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well researchers can track HIV-related health and immune changes over time by collecting blood and other samples. It may help you and your care team by creating detailed monitoring, even if your HIV diagnosis is new or still being evaluated.
This trial helps hospitals find undiagnosed HIV by improving testing and care. It supports healthcare teams to identify HIV in people with certain conditions and ensures those diagnosed get connected to treatment.
This study looks at how to make hepatitis C testing and treatment easier to access in Canada. It involves different people, like those at risk, healthcare workers, and policy makers, to find better ways to offer care.
This study tests a new tool that helps emergency department doctors identify patients who might have hepatitis C. If it works, it could lead to more people getting tested and treated for the virus.
This trial studies point-of-care (on-site) testing to find hepatitis C in adults who are at higher risk. If hepatitis C is found, earlier detection can help you get connected to care sooner.
This trial tests how acceptable it is for people who use services outside traditional clinics to be screened for hepatitis B, hepatitis C, and HIV during the same visit. If you join, you would be asked to participate and provide consent for the screening process.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.